• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNAs 与癌症中 DNA 甲基化的相互作用。

Crosstalk between miRNAs and DNA Methylation in Cancer.

机构信息

Department of Internal Medicine, Division of Pulmonary Diseases and Critical Care Medicine, Virginia Commonwealth University, 1250 E. Marshall Street, Richmond, VA 23298, USA.

出版信息

Genes (Basel). 2023 May 12;14(5):1075. doi: 10.3390/genes14051075.

DOI:10.3390/genes14051075
PMID:37239435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10217889/
Abstract

miRNAs are some of the most well-characterized regulators of gene expression. Integral to several physiological processes, their aberrant expression often drives the pathogenesis of both benign and malignant diseases. Similarly, DNA methylation represents an epigenetic modification influencing transcription and playing a critical role in silencing numerous genes. The silencing of tumor suppressor genes through DNA methylation has been reported in many types of cancer and is associated with tumor development and progression. A growing body of literature has described the crosstalk between DNA methylation and miRNAs as an additional layer in the regulation of gene expression. Methylation in miRNA promoter regions inhibits its transcription, while miRNAs can target transcripts and subsequently regulate the proteins responsible for DNA methylation. Such relationships between miRNA and DNA methylation serve an important regulatory role in several tumor types and highlight a novel avenue for potential therapeutic targets. In this review, we discuss the crosstalk between DNA methylation and miRNA expression in the pathogenesis of cancer and describe how miRNAs influence DNA methylation and, conversely, how methylation impacts the expression of miRNAs. Finally, we address how these epigenetic modifications may be leveraged as biomarkers in cancer.

摘要

miRNAs 是基因表达最具特征性的调控因子之一。它们在多个生理过程中不可或缺,其异常表达通常会导致良性和恶性疾病的发病机制。同样,DNA 甲基化是一种影响转录的表观遗传修饰,在沉默许多基因方面发挥着关键作用。许多类型的癌症中都报道了肿瘤抑制基因通过 DNA 甲基化沉默,并且与肿瘤的发生和发展有关。越来越多的文献描述了 DNA 甲基化和 miRNA 之间的串扰,作为基因表达调控的另一个层面。miRNA 启动子区域的甲基化抑制其转录,而 miRNA 可以靶向转录本,进而调节负责 DNA 甲基化的蛋白质。miRNA 和 DNA 甲基化之间的这种关系在几种肿瘤类型中起着重要的调节作用,并为潜在的治疗靶点提供了新的途径。在这篇综述中,我们讨论了 DNA 甲基化和 miRNA 表达在癌症发病机制中的相互作用,并描述了 miRNA 如何影响 DNA 甲基化,以及反之亦然,甲基化如何影响 miRNA 的表达。最后,我们探讨了这些表观遗传修饰如何作为癌症的生物标志物加以利用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad6/10217889/abca780c2f06/genes-14-01075-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad6/10217889/125d48306712/genes-14-01075-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad6/10217889/71ccd94faf38/genes-14-01075-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad6/10217889/abca780c2f06/genes-14-01075-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad6/10217889/125d48306712/genes-14-01075-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad6/10217889/71ccd94faf38/genes-14-01075-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad6/10217889/abca780c2f06/genes-14-01075-g003.jpg

相似文献

1
Crosstalk between miRNAs and DNA Methylation in Cancer.miRNAs 与癌症中 DNA 甲基化的相互作用。
Genes (Basel). 2023 May 12;14(5):1075. doi: 10.3390/genes14051075.
2
Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs.膀胱癌中的表观遗传修饰:DNA甲基化与微小RNA之间的相互作用
Front Immunol. 2025 Feb 5;16:1518144. doi: 10.3389/fimmu.2025.1518144. eCollection 2025.
3
Mutual regulation of microRNAs and DNA methylation in human cancers.人类癌症中微小RNA与DNA甲基化的相互调控
Epigenetics. 2017 Mar 4;12(3):187-197. doi: 10.1080/15592294.2016.1273308. Epub 2017 Jan 6.
4
An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.肺癌的综合表观基因组-转录组图谱揭示了具有诊断和治疗意义的新型甲基化驱动基因。
Theranostics. 2021 Mar 11;11(11):5346-5364. doi: 10.7150/thno.58385. eCollection 2021.
5
Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.急性淋巴细胞白血病中 MIR22 的基因沉默涉及组蛋白修饰,而与启动子 DNA 甲基化无关。
Br J Haematol. 2010 Jan;148(1):69-79. doi: 10.1111/j.1365-2141.2009.07920.x. Epub 2009 Oct 5.
6
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.miRNA 表达与 DNA 甲基化的串扰驱动乳腺癌的激素依赖性表型。
Genome Med. 2021 Apr 29;13(1):72. doi: 10.1186/s13073-021-00880-4.
7
Regulation of microRNAs by epigenetics and their interplay involved in cancer.表观遗传学对微小RNA的调控及其在癌症中的相互作用。
J Exp Clin Cancer Res. 2013 Nov 22;32(1):96. doi: 10.1186/1756-9966-32-96.
8
Epigenetic targets in human neoplasms.人类肿瘤中的表观遗传学靶点。
Epigenomics. 2010 Apr;2(2):221-32. doi: 10.2217/epi.10.1.
9
Genome-wide epigenetic regulation of miRNAs in cancer.癌症中 miRNA 的全基因组表观遗传调控。
Cancer Res. 2013 Jan 15;73(2):473-7. doi: 10.1158/0008-5472.CAN-12-3731. Epub 2013 Jan 10.
10
DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.肿瘤抑制 miRNA 基因在慢性淋巴细胞白血病中的 DNA 甲基化。
Epigenomics. 2015;7(3):461-73. doi: 10.2217/epi.15.6. Epub 2015 Feb 4.

引用本文的文献

1
Identification of Epigenetic Regulatory Networks of Gene Methylation-miRNA-Transcription Factor Feed-Forward Loops in Basal-like Breast Cancer.基底样乳腺癌中基因甲基化-微小RNA-转录因子前馈环的表观遗传调控网络鉴定
Cells. 2025 Aug 10;14(16):1235. doi: 10.3390/cells14161235.
2
Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?miR-10a是否为一种调节高级别膀胱癌增殖和侵袭的肿瘤抑制因子?
Oncol Res. 2025 May 29;33(6):1377-1382. doi: 10.32604/or.2025.055306. eCollection 2025.
3
Profiling the cell-specific small non-coding RNA transcriptome of the human placenta.

本文引用的文献

1
The Double Face of miR-708: A Pan-Cancer Player with Dissociative Identity Disorder.miR-708 的双重面孔:一个具有分离性身份障碍的泛癌“玩家”。
Genes (Basel). 2022 Dec 16;13(12):2375. doi: 10.3390/genes13122375.
2
Extracellular Vesicle MicroRNA in Malignant Pleural Effusion.恶性胸腔积液中的细胞外囊泡 microRNA。
Genes (Basel). 2022 Nov 19;13(11):2159. doi: 10.3390/genes13112159.
3
Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.局限性前列腺癌患者尿液中的游离微小RNA
分析人类胎盘细胞特异性小非编码RNA转录组
Sci Rep. 2025 Apr 26;15(1):14666. doi: 10.1038/s41598-025-98939-4.
4
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials.靶向人类癌症中的调控性非编码RNA:临床试验的现状
Pharmaceutics. 2025 Apr 4;17(4):471. doi: 10.3390/pharmaceutics17040471.
5
Integrative Analysis of DNA Methylation and microRNA Reveals GNPDA1 and SLC25A16 Related to Biopsychosocial Factors Among Taiwanese Women with a Family History of Breast Cancer.DNA甲基化与微小RNA的综合分析揭示了与有乳腺癌家族史的台湾女性生物心理社会因素相关的GNPDA1和SLC25A16 。
J Pers Med. 2025 Mar 30;15(4):134. doi: 10.3390/jpm15040134.
6
Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma.用于肝细胞癌早期诊断的循环肿瘤DNA甲基化标志物
Clin Exp Med. 2025 Mar 14;25(1):83. doi: 10.1007/s10238-025-01599-x.
7
Profiling the cell-specific small non-coding RNA transcriptome of the human placenta.分析人类胎盘细胞特异性小非编码RNA转录组
Res Sq. 2025 Feb 12:rs.3.rs-5953518. doi: 10.21203/rs.3.rs-5953518/v1.
8
Current molecular understanding of central nervous system schwannomas.中枢神经系统神经鞘瘤的当前分子学认识。
Acta Neuropathol Commun. 2025 Feb 5;13(1):24. doi: 10.1186/s40478-025-01937-w.
9
Epigenetics of Conjunctival Melanoma: Current Knowledge and Future Directions.结膜黑色素瘤的表观遗传学:当前认知与未来方向。
Cancers (Basel). 2024 Oct 31;16(21):3687. doi: 10.3390/cancers16213687.
10
Metformin as a Potential Therapeutic Agent in Breast Cancer: Targeting miR-125a Methylation and Epigenetic Regulation.二甲双胍作为乳腺癌的潜在治疗药物:靶向miR-125a甲基化和表观遗传调控
Int J Mol Cell Med. 2024;13(3):272-285. doi: 10.22088/IJMCM.BUMS.13.3.272.
Cancers (Basel). 2022 May 12;14(10):2388. doi: 10.3390/cancers14102388.
4
DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer.DNA甲基转移酶1抑制微小RNA-497并提高GPRC5A表达,以促进乳腺癌的化疗耐药性和转移。
Cancer Cell Int. 2022 Mar 7;22(1):112. doi: 10.1186/s12935-022-02466-5.
5
A Structural View of miRNA Biogenesis and Function.微小RNA生物合成与功能的结构视角
Noncoding RNA. 2022 Jan 18;8(1):10. doi: 10.3390/ncrna8010010.
6
DNA methyltransferase 3 beta regulates promoter methylation of microRNA-149 to augment esophageal squamous cell carcinoma development through the ring finger protein 2/Wnt/β-catenin axis.DNA 甲基转移酶 3β 通过调节 microRNA-149 的启动子甲基化,通过环状指蛋白 2/Wnt/β-连环蛋白轴增强食管鳞状细胞癌的发展。
Bioengineered. 2022 Feb;13(2):4010-4027. doi: 10.1080/21655979.2022.2031411.
7
A Novel Urinary miRNA Biomarker for Early Detection of Colorectal Cancer.一种用于早期检测结直肠癌的新型尿液微小RNA生物标志物。
Cancers (Basel). 2022 Jan 17;14(2):461. doi: 10.3390/cancers14020461.
8
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
Non-coding RNAs as liquid biopsy biomarkers in cancer.非编码 RNA 作为癌症的液体活检生物标志物。
Br J Cancer. 2022 Feb;126(3):351-360. doi: 10.1038/s41416-021-01672-8. Epub 2022 Jan 10.
10
Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.尿外泌体 miRNA 作为膀胱癌的生物标志物及 miR-93-5p 在膀胱癌中作用机制的实验验证。
BMC Cancer. 2021 Dec 3;21(1):1293. doi: 10.1186/s12885-021-08926-x.